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Abstract
Laboratory mice have long been an invaluable tool in biomedical science and have made significant contributions in research 
into life-threatening diseases. However, the translation of research results from mice to humans often proves difficult due to 
the incomplete nature of laboratory animal-based research. Hence, there is increasing demand for complementary methods 
or alternatives to laboratory mice that can better mimic human physiological traits and potentially bridge the translational 
research gap. Under these circumstances, the natural/naturalized mice including “wild”, “dirty”, “wildling”, and “wilded” 
systems have been found to better reflect some aspects of human pathophysiology. Here, we discuss the pros and cons of the 
laboratory mouse system and contemplate how wild mice and wild microbiota are able to help in refining such systems to 
better mimic the real-world situation and contribute to more productive translational research.
Laboratory mice (lab mice) are a mainstay in current bio-
medical science that have contributed to pivotal discover-
ies leading to the development of life-saving therapeutics 
(Kleinert et al. 2018; Rust 1982). The main advantage of 
using lab mice is the ability to control genetic and environ-
mental factors, which are key determinants for the experi-
mental outcome of biomedical research. The use of lab mice, 
mainly comprising a wide range of inbred strains, enables 
researchers to control and even manipulate their genetic 
components, permitting the elucidation of the causal rela-
tionship between the gene and the specific phenotype of cells 
and/or animals. At the same time, the standardized envi-
ronmental conditions in the present-day animal vivarium 
are tightly controlled and have led to synchronization of the 
majority of environmental factors (for example, day/night 
cycle, temperature, diet, and water supplementation, etc.), 
which potentially affects the experimental outcome. (Reza 
Khorramizadeh and Saadat 2020). Moreover, lab mice can 
be maintained in an artificial microbial environment, known 
as specific pathogen free (SPF), in which the exposure of lab 
mice to the major pathosymbiotics (bacteria, viruses, fungi, 
and worms) is highly restricted compared with that of mice 
in a natural habitat (Nguyen et al. 2015). These advantages 
of the laboratory mouse system have drastically enhanced 
the reproducibility of biomedical research and have allowed 
researchers to leverage a “one gene–one disease” paradigm.
However, there is growing concern for the validity of 
laboratory animal models that do not properly manifest 
human pathophysiological traits (Mak et al. 2014; Pedersen 
and Babayan 2011; Seok et al. 2013). For example, despite 
the astronomical costs of animal model-based preclinical 
research, the overall success rate of subsequent drug devel-
opment trials is just 14% (Wong et al. 2019). Furthermore, 
mouse and human studies have occasionally come to con-
trasting conclusions, which has cast doubt on the effective-
ness of lab mice in translational research (Fisher et al. 1996; 
Naqvi et al. 2019; Puellmann et al. 2006; Seok et al. 2013). 
Meanwhile, recent studies have indicated that genetic and 
environmental regularity in lab mice may be a potential 
cause of these discrepancies (Churchill et al. 2004; Viney 
et al. 2015). For instance, the majority of current immuno-
logical knowledge was primarily gleaned from a few inbred 
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mouse strains, thereby limiting the amount of noise caused 
by segregating genetic variations. Thus, much of our bio-
medical knowledge, is built on a very small number of indi-
vidual mice; this would correspond to only 5 to 10 human 
individuals, which would hardly be enough to emulate the 
complex genetic diversity and vulnerability of human beings 
(Pedersen and Babayah 2011). Moreover, together with 
genetic factors, the environmental variables of age, socio-
economic status, climate, nutritional status, health status, 
etc.—none of which can be accounted for in lab mice—have 
also been shown to affect human immune responses (Brodin 
et al. 2015; Rohr et al. 2011). Above all other environmental 
influencers, it has recently become clear that microbial com-
munities, known as the microbiota, play an invaluable role 
in the physiology of hosts. Microbiota have been shown to 
influence processes from organ development/morphogen-
esis and metabolism to the development, differentiation, 
and function of host immunity (Belkaid and Hand 2014; 
Sommer and Bäckhed 2013). Indeed, germ-free (GF) mice, 
unexposed to microorganisms, have been found to exhibit 
a broad spectrum of developmental and functional impair-
ment in the immune system, directly linked to susceptibility 
to various immunological disorders including cancer, aller-
gies, inflammatory bowel disease (IBD), and autoimmune 
diseases (Round and Mazmanian 2009). There is therefore 
increasing demand in various areas of biomedical research 
to develop an alternative and/or complementary system for 
lab mice that can minimize the chasm between basic and 
translational research (Masopust et al. 2017; von Scheidt 
et al. 2017).
The study of wild mice seems to be an alluring alterna-
tive with which to compensate for the limited translational 
value of lab mice (Poh 2019; Nobs and Elinav 2019). In 
contrast to lab mice, wild or free-living mice exhibit pre-
served genetic diversity as well as environmental effects, 
which, as stated above, are the key determinants of human 
ecophysiology. Despite the extreme lack of research involv-
ing wild mice, previous studies have pinpointed human-like 
immunological traits in such mice—for example, a ‘primed’ 
immune state and its potential link with the cumulative 
exposure to microbes in nature—compared with mice liv-
ing in a laboratory vivarium (Table 1) (Abolins et al. 2017, 
2011; Beura et al. 2016; Boysen et al. 2011; Lochmiller 
et al. 1991). Indeed, a recent study by Lalit and colleagues 
showed that immune systems in lab mice have phenocop-
ied a human neonate-like immune status, compared with 
those of wild mice, in which human adult-like immune traits 
were observed (Beura et al. 2016). The unique immunologi-
cal characteristics of feral mice are highly reminiscent of 
human immune traits, suggesting that wild mouse systems 
may be a potential tool to bridge the gap between lab mice 
and translational research. Studies have shown that wild 
mice have a complex and diverse microbiome, including a 
mycobiome, archaeome, and parasitome, similar to those 
found in humans (Table 2) (Beura et al. 2016; Lavrinienko 
et al. 2018; Linnenbrink et al. 2013; Rosshart et al. 2019, 
2017; Song et al. 2021; Suzuki and Nachman 2016; Weldon 
et al. 2015; Williams et al. 2018). As the microbiome is 
known to configure host physiology and pathophysiology, 
the higher orders of the microbial communities in wild mice, 
shaped by natural selection in the wild, might play distinct 
roles in host fitness. For example, primed immune traits in 
wild mice have shown a strong association with age and 
infectious burden with remarkable heterogeneity (Abolins 
et al. 2017; Beura et al. 2016), indicating that cumulative 
microbial exposure may be one of the key drivers of immune 
activation/maturation in wild mice, in a manner similar to 
that seen in humans (Salgame et al. 2013; Virgin et al. 2009). 
Furthermore, the natural gut microbiota has been shown to 
improve the outcome of viral infection and tumorigenesis in 
lab mice (Rosshart et al. 2017). Although it would be some-
what premature to discuss the validity of the use of wild 
mice in current biomedical research, as very little research 
has yet been carried out, the studies cited above collectively 
highlight the potential of the wild mouse system as a tool in 
translational research that can better mimic the biological 
evolution of humans and diseases.
Human beings have co-evolved alongside trillions of 
microbes, considered to be a “hidden organ” due to their 
immense impact on human health and disease (Cho and 
Blaser 2012; O’Hara and Shanahan 2006; Pflughoeft and 
Versalovic 2012). Recent advances in microbiome research 
have outlined the indispensable roles of microbiota in the 
induction, training, and function of the host immune system 
in both humans as well as rodents (Belkaid and Hand 2014), 
and microbial exposure to acute and chronic pathogens has 
been shown to control immune variation in humans (Sal-
game et al. 2013; Virgin et al. 2009). In addition, individu-
als with a heavy helminth burden have been found to show 
compromised vaccination-induced immune responses with 
Bacillus Calmette-Guerin (BCG) and cholera (Cooper et al. 
2001; Elias et al. 2001). Meanwhile, a number of studies 
have shown the versatility of microbiota in modulating host 
physiology and functions in rodent (Belkaid and Hand 2014; 
Round and Mazmanian 2009; Sommer and Bäckhed 2013; 
Surana and Kasper 2014). However, as the majority of lab 
mice are raised in an SPF vivarium, as a result of which they 
have extremely simple and controlled microbiota, the lack 
of microbial diversity and complexity in lab mice might be 
an environmental deficit that decreases the value of lab mice 
to human translational research. Indeed, recent studies have 
exquisitely demonstrated how the “dirty” microbiota from 
wild mice can be used as a tool to recapitulate naturally 
selected microbial niches to bolster the translational validity 
of lab mice (Beura et al. 2016; Rosshart et al. 2019, 2017). 
Lalit and colleagues were the first to show the potential 
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of dirty microbiota as a valuable tool in lab mouse-based 
immunology by co-housing pet-store mice with lab mice 
(Beura et al. 2016). Intriguingly, co-housing with pet-store 
mice was sufficient to increase the differentiated effector 
memory T cell population  (CD44hi), which produces high 
levels of Granzyme B, in the peripheral immune system of 
the lab mice. Moreover, the authors found de novo popu-
lating  CD8+ T cells, which have a tissue-resident memory 
T cell  (TRM) phenotype, in non-lymphoid organs of co-
housed C57BL/6 mice, similar to those seen in human tis-
sues. Finally, the transcriptional signatures in blood cells 
from the lab mice that were co-housed with pet-store mice 
were found to have reshaped signature patterns that more 
closely mirrored adult than neonatal ones. Altogether, these 
studies highlight that, beyond genetic elements, microbiota 
play a key role in determining basal immunological states, 
and suggest that dirty microbiota may be of use in restoring 
physiological microbial states and provoking immunologi-
cal traits observed in human beings. Indeed, another study 
discovered that sequential infection with defined patho-
gens including herpesvirus, influenza, and helminth in lab 
mice elicited altered transcriptome signatures that partially 
recapitulated the immunological features triggered by dirty 
microbiota (Reese et al. 2016). This suggests that selective 
microbial exposure (termed “defined dirty”) can be used to 
install human-like immunological traits in lab mice.
To study the importance of host–microbe interaction on 
host physiology, Rehermann’s group at NIH has trapped 
more than 800 wild mice from eight different locations, 
characterized their gut microbiota and compared them with 
those of lab mice (Rosshart et al. 2017). As expected, wild 
mice exhibited more diverse and complex microbiome com-
positions with well-preserved natural features, including 
viral and fungal species, compared to those of lab mice. 
Interestingly, the wild microbiome can be transferred to, and 
maintained in, lab mice over several generations (up  5th gen-
eration) without notable changes, suggesting that there is rel-
atively minor impact of other environmental factors, includ-
ing temperature, day/night cycle, diet, and social structure, 
on the microbiome community (Rosshart et al. 2019, 2017). 
Similar to these results, we have documented the resilience 
and stability of the wild microbiome in inbred mice up to the 
15th generation (unpublished data), strengthening the poten-
tial value of “dirty” microbiota in translational research.
The potential benefits of the wild microbiome to the 
fitness of lab mice have been evaluated in a disease con-
text. Following influenza infection, compared with labora-
tory mice (lab) or laboratory microbiome-transferred mice 
(labR), wild microbiome-implanted mice (wildR) showed 
significantly decreased mortality (lab/labR: 83% vs. wildR: 
8%), viral burden, and lung pathology. Additionally, 
researchers have found that fecal microbiota transplantation 
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against inflammation-induced neoplastic development. Alto-
gether, these results suggest that the “natural microbiota” 
(microbiota from free-living mice and humans) have co-
evolved to promote host fitness and survival under natural 
selection pressure, to establish a symbiotic host–microbe 
interaction that is integral to host physiology, particularly 
in the case of the immune system. To take “natural micro-
biota” engraftment a step further, the same group devised 
a model in which they transferred C57BL/6 embryos into a 
pseudo-pregnant dam, captured in the wild (Rosshart et al. 
2019). The pups from the wild dams, called “wildlings”, 
were shown to retain much of the wild microbiota via verti-
cal transmission from the wild dam, but with the less com-
plex genetics of C57BL/6. In a manner similar to that of 
the natural microbiota engraftment system, wildlings have 
well-retained naturally derived microbiome compositions, 
such as those of the mycobiome and virome, that can be ver-
tically transferred to their offspring for multiple generations 
without notable diversification, indicating the resilience of 
the natural microbiome. Next, they comprehensively profiled 
and compared the immune states of lab, wild, and wildling 
mice to estimate the contribution of genetics (wild vs. wild-
ling) or microbiome (lab vs. wildling) on the host immune 
system by cytometry, using time of flight (CyTOF) and RNA 
sequencing-based transcriptome analysis (RNAseq). They 
found more similar transcriptome patterns of blood mono-
nuclear cells from wildlings when compared with wild mice 
than lab mice, despite their genetic differences. Intriguingly, 
these researchers have shown the considerable influence of 
the microbiome on immune cells in central lymphoid tissue 
but not in non-lymphoid tissue, which indicates that genetics 
and microbial composition combine to influence host immu-
nity. Finally, the translational value of wilding was evaluated 
by the retrospective validation of two well-known models, 
CD28-super-agonist (CD28SA) for the treatment of auto-
immune disease, inflammatory disease, and transplantation 
(Puellmann et al. 2006) and anti-TNFα treatment for sepsis 
(Fisher et al. 1996), which have shown discordant results 
in lab mouse and human systems. Surprisingly, the treat-
ment of CD28SA or anti-TNFα in wildlings, but not in lab 
mice, phenocopied the trait of immune responses observed 
in humans. Altogether, these results cast doubt on the valid-
ity of the current laboratory mouse system and suggest that 
wildlings may be a promising complement to lab mice for 
translational research in immunology.
In support of a wild/dirty/wildling system, Graham’s 
research group at Princeton University has recently built an 
outdoor mouse enclosure with eight wedge-shaped pens cov-
ering nearly 1,500m2, and has put lab mice in these “farms” 
to re-wild them in natural environments; such mice are 
termed “wilded”. This enables researchers to manipulate the 
key determinants in animal-based biomedical research, such 
as host genetics, age, and sex, while preserving naturally 
occurring environmental pressure (Graham 2021; Leung 
et al. 2018). Interestingly, re-wilding of lab mice has been 
found to partially phenocopy the ‘primed’ immune traits that 
exist in wild mice and humans (Leung et al. 2018; Yeung 
et al. 2020). Furthermore, a recent study has beautifully out-
lined the relative contributions of genetic versus environ-
mental factors that govern inflammatory immune responses 
by re-wilding lab mice carrying nod2 or atg16l1 mutations, 
the well-known susceptibility mutations in inflammatory 
bowel disease (Lin et al. 2020). Overall, their results sug-
gest that re-wilding lab mice could facilitate exploration of 
the effects of the natural environment in wildlife.
While laboratory animal-based research has led to nota-
ble advances in modern biomedical research, it has become 
apparent that lab mice are not always reliable in recapitulat-
ing human physiology and pathophysiology. This has led to 
significant demand for a novel platform that can mitigate the 
flaws or limitations of the lab mouse system. Accordingly, 
recent studies involving wild, dirty, wildling, and wilded 
systems have proposed these as potential complementary 
systems that maximize the translational validity of lab mice. 
Nevertheless, despite having significant congruence with 
human physiology, wild mice may not be technically easy 
to incorporate into general biomedical research facilities due 
to difficulties with animal supplementation and maintenance. 
As an alternative to the use of wild mice, FMT of natural 
microbiota from dirty, wildling, and wilded mice has been 
shown to elicit the recapitulation of major human pathophys-
iological traits in lab mice and is a promising tool of poten-
tial use in translational research. However, the application 
of these systems in current biomedical research poses the 
following difficulties: firstly, as a result of naturally occur-
ring infections, these animals pose biosecurity and zoonotic 
issues that restrict their husbandry to facilities with biosafety 
level 2 or higher; furthermore, there is a huge difference in 
the overall composition of the microbiome depending on 
the source of wild mice, which may potentially lead to dis-
cordant research outcomes when using these systems. Thus, 
while these systems may not serve as a substitute for the 
use of lab mice in current biomedical research, they can be 
of use in enhancing the validity and translational power of 
animal-based preclinical research in human physiology and 
pathophysiology.
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